Interim report
Page 1
GlaxoSmithKline Pharmaceuticals Limited Registered Office : Dr. Annie Besant Road , Mumbai - 400 030 CIN : L24239MH1924PLC001151 Tel No : +91 22 2495 9595 Fax No : +91 22 24959494 STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30th JUNE 2021 ( Rs . in Lakhs ) Income 1 Revenue from operations 2 Other income ( Refer Note 3 ) 3 Total Income ( 1 + 2 ) Particulars Corresponding 3 months ended 30.06.2021 Preceding 3 months ended 31.03.2021 3 months ended 30.06.2020 Year ended 31.03.2021 ( Unaudited ) ( Unaudited ) ( Refer Note 2 ) ( Unaudited ) ( Audited ) 77346 3173 80727 2961 64865 5779 80519 83688 70644 319373 11019 330392 Expenses ( a ) Cost of materials consumed 16714 13198 10672 45264 ( b ) Purchases of stock - in - trade 14129 22580 14842 88011 ( c ) Changes in inventories of finished goods , stock - in- trade and work - in - progress ( 1359 ) ( 2861 ) 219 ( 2753 ) ( d ) Employee benefits expense 16779 14955 15192 61469 ( e ) Finance costs 79 63 108 353 ( f ) Depreciation and amortisation expense 1771 1785 2177 7928 ( g ) Other expenses 16014 15976 12505 57887 4 Total expenses 64127 65696 5 Profit before exceptional items and tax ( 3-4 ) 16392 17992 55715 14929 258159 72233 6 Exceptional item tional items [ ( charge ) ] ( Refer Note 4 ) ( 11900 ) ( 17260 ) 7 Profit before tax ( 5 + 6 ) 8 Tax expense xpense ( a ) Current tax ( b ) Deferred tax 9 Profit for the period / year ( 7-8 ) 16392 6092 14929 54973 4700 3738 3811 18430 ( 348 ) 1080 22 12040 1274 11096 787 35756 10 Other comprehensive income ( i ) Items that will not be reclassified to profit or loss 765 ( 405 ) ( 274 ) ( ii ) Income tax relating to items that will not be reclassified to profit or loss 11 Total comprehensive income for the period ( 9 + 10 ) Paid - up equity share capital ( face value per share Rs . 10 ) Other equity Earnings per share ( EPS ) ( of Rs . 10 each ) Basic and diluted EPS after Exceptional items ( Rs . ) Basic and diluted EPS before Exceptional items ( Rs . ) ( 193 ) 102 12040 1846 10793 16941 16941 16941 69 35551 16941 134853 7.11 0.75 6.55 21.11 7.11 7.78 6.55 31.32 Not Annualised A Viz